Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN5A | Q14524 | 10/20 | 0.45 |
| ▸ | SCN9A | Q15858 | 11/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.40 |
| ▸ | SCN8A | Q9UQD0 | 3/20 | 0.39 |
| ▸ | SCN1A | P35498 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20096055 | 0.88 | SCN5A (0.50) | SCN5ASCN9ACYP3A4SCN8ASCN1A | |
| SCHEMBL20095918 | 0.87 | SCN5A (0.44) | SCN5ASCN9ACYP3A4SCN8ASCN1A | |
| SCHEMBL20115559 | 0.82 | SCN5A (0.48) | SCN5ASCN9ACYP3A4SCN8ASCN1A | |
| SCHEMBL20095953 | 0.82 | SCN9A (0.46) | SCN5ASCN9ACYP3A4SCN8ASCN1A | |
| SCHEMBL20096222 | 0.82 | SCN9A (0.46) | SCN5ASCN9ACYP3A4SCN8ASCN1A | |
| SCHEMBL20096031 | 0.80 | SCN5A (0.45) | SCN5ASCN9ACYP3A4SCN8ASCN1A | |
| SCHEMBL20115722 | 0.79 | SCN5A (0.71) | SCN5ASCN9ACYP3A4SCN8ASCN1A | |
| SCHEMBL20115622 | 0.78 | SCN5A (0.65) | SCN5ASCN9ACYP3A4 | |
| SCHEMBL20095900 | 0.77 | SCN9A (0.45) | SCN5ASCN9ACYP3A4SCN8ASCN1A | |
| SCHEMBL20115715 | 0.76 | SCN5A (0.66) | SCN5ASCN9ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3532462-B1 | ACYL SULFONAMIDE NAV1.7 INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2021-10-13 | — | — | EP | disclosed |
| WO-2018081384-A1 | ACYL SULFONAMIDE NAV1.7 INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2018-05-03 | — | — | WO | disclosed |